Patients with COVID-19, severe pneumonia, or ARDS had elevated levels of interleukin (IL)-6 [22,23], IL-10 [22,23], and granulocyte colony-stimulating factor (G-CSF) [22,24,25]. This evidence concerns the gene CSF3 and acute respiratory distress syndrome.